Cytokinetics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-751.94	-589.53	-526.24	-388.96	-215.31	-127.29
Depreciation & Amortization	9.65	9.53	11.89	5.81	2.28	1.83
Loss (Gain) From Sale of Assets	0.05	0.05	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	2.84	-
Loss (Gain) From Sale of Investments	-0.04	-0.02	0.04	0.11	-	-0.57
Stock-Based Compensation	108.03	97.84	72.07	47.85	26.83	17.62
Other Operating Activities	193.4	50.58	24.83	60.37	32.38	32.46
Change in Accounts Receivable	-1.56	-15.37	-1.14	56.67	-47.4	0.74
Change in Accounts Payable	8.88	-4.48	-3.48	4.52	1.06	-0.11
Change in Unearned Revenue	1.61	52.37	-	-87	-	87
Change in Other Net Operating Assets	-0.99	3.14	7.71	1.1	54.8	-2.74
Operating Cash Flow	-432.93	-395.89	-414.33	-299.52	-142.52	8.94
Capital Expenditures	-20.45	-3.91	-1.42	-11.34	-48.87	-11.05
Investment in Securities	219.17	-549.19	240.67	-250.8	-98.91	-185.46
Investing Cash Flow	198.72	-553.1	239.25	-262.13	-147.78	-196.52
Long-Term Debt Issued	-	-	-	523.59	-	-
Long-Term Debt Repaid	-	-9.62	-0.86	-188.93	-	-
Net Debt Issued (Repaid)	315.76	-9.62	-0.86	334.66	-	-
Issuance of Common Stock	27.81	759.86	182.69	17.54	324.85	234.23
Repurchase of Common Stock	-2.43	-19.63	-10.52	-9.6	-4.87	-2.26
Other Financing Activities	75	200	50	173.56	-	2.15
Financing Cash Flow	416.14	930.61	221.32	516.17	319.98	234.12
Foreign Exchange Rate Adjustments	-0.61	0.21	-0.02	-	-	-
Net Cash Flow	181.32	-18.17	46.22	-45.48	29.68	46.55
Free Cash Flow	-453.38	-399.8	-415.75	-310.85	-191.39	-2.11
Free Cash Flow Margin	-519.87%	-2164.10%	-5521.23%	-328.64%	-271.76%	-3.78%
Free Cash Flow Per Share	-3.81	-3.57	-4.31	-3.46	-2.49	-0.03
Cash Interest Paid	20.51	25.97	10.3	15.17	9.18	9.62
Levered Free Cash Flow	-320.96	-241.49	-260.37	-127.01	-179.83	-69
Unlevered Free Cash Flow	-260.88	-187.42	-224.33	-95.04	-161.5	-44.83
Change in Working Capital	7.93	35.66	3.09	-24.7	8.46	84.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.